Jefferies Group’s Halozyme HALO Stock Holding History

Jefferies Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-200,000	Closed	-$9.08M	–	1833
2021 Q2	$9.08M	Buy	+200,000	New	+$8.85M	0.06%	295

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jefferies Group's HALO Position: Q2 2022 in Review

Jefferies Group sold out of Halozyme (HALO) in Q2 2022, closing a stake of 14,797 shares — an estimated $590K sold.

Jefferies Group first reported a position in HALO in Q3 2013 and held it in 10 quarters. The position peaked at $816K in Q2 2019. 367 funds tracked by Wall St. Rank hold HALO as of Q2 2022.

Jefferies Group reported no remaining Halozyme position as of Q2 2022 after selling out during the quarter.
Jefferies Group sold 14,797 Halozyme shares in Q2 2022, an estimated $590K.
Jefferies Group first reported a position in Halozyme in Q3 2013 and held it in 10 quarters.
Jefferies Group's Halozyme position peaked at $816K in Q2 2019.
367 funds tracked by Wall St. Rank held Halozyme as of Q2 2022.

Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.